G. Wynne Aherne

5.7k total citations
131 papers, 4.3k citations indexed

About

G. Wynne Aherne is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, G. Wynne Aherne has authored 131 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 40 papers in Oncology and 22 papers in Organic Chemistry. Recurrent topics in G. Wynne Aherne's work include Colorectal Cancer Treatments and Studies (20 papers), Biochemical and Molecular Research (19 papers) and Acute Lymphoblastic Leukemia research (19 papers). G. Wynne Aherne is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Biochemical and Molecular Research (19 papers) and Acute Lymphoblastic Leukemia research (19 papers). G. Wynne Aherne collaborates with scholars based in United Kingdom, United States and France. G. Wynne Aherne's co-authors include V. Marks, E. M. Piall, Anthea Hardcastle, Ray J. Briggs, Ann L. Jackman, Nicola J. Curtin, Michelle D. Garrett, Adrian L. Harris, Paul Workman and Martin Rowlands and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

G. Wynne Aherne

130 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Wynne Aherne United Kingdom 40 2.1k 1.3k 479 364 320 131 4.3k
Timothy W. Synold United States 39 2.4k 1.2× 2.3k 1.8× 148 0.3× 586 1.6× 651 2.0× 194 5.9k
Dean J. Naisbitt United Kingdom 47 859 0.4× 677 0.5× 426 0.9× 261 0.7× 145 0.5× 200 6.9k
Hans Ehrsson Sweden 36 1.1k 0.5× 1.2k 0.9× 313 0.7× 218 0.6× 290 0.9× 121 3.6k
David C. Thompson United States 31 1.7k 0.8× 879 0.7× 141 0.3× 209 0.6× 258 0.8× 90 4.2k
Hans Glaumann Sweden 46 1.9k 0.9× 772 0.6× 215 0.4× 157 0.4× 848 2.6× 210 7.3k
Nicholas R. Bachur United States 35 1.8k 0.9× 1.5k 1.2× 602 1.3× 213 0.6× 299 0.9× 96 4.6k
Toshihisa Ishikawa Japan 47 3.1k 1.5× 4.4k 3.4× 364 0.8× 366 1.0× 541 1.7× 156 7.7k
Michaël Thomas United States 40 2.0k 1.0× 596 0.5× 430 0.9× 92 0.3× 314 1.0× 166 5.4k
E. A. de Bruijn Belgium 32 2.0k 1.0× 1.4k 1.1× 134 0.3× 164 0.5× 635 2.0× 128 4.9k
John L. Gollan United States 34 1.4k 0.7× 998 0.8× 53 0.1× 85 0.2× 608 1.9× 108 6.1k

Countries citing papers authored by G. Wynne Aherne

Since Specialization
Citations

This map shows the geographic impact of G. Wynne Aherne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Wynne Aherne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Wynne Aherne more than expected).

Fields of papers citing papers by G. Wynne Aherne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Wynne Aherne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Wynne Aherne. The network helps show where G. Wynne Aherne may publish in the future.

Co-authorship network of co-authors of G. Wynne Aherne

This figure shows the co-authorship network connecting the top 25 collaborators of G. Wynne Aherne. A scholar is included among the top collaborators of G. Wynne Aherne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Wynne Aherne. G. Wynne Aherne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Couty, S., Isaac M. Westwood, Andrew Kalusa, et al.. (2013). The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design. Oncotarget. 4(10). 1647–1661. 17 indexed citations
2.
Walton, Mike I., Paul D. Eve, Angela Hayes, et al.. (2012). CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. Clinical Cancer Research. 18(20). 5650–5661. 69 indexed citations
3.
Walton, Michael I., Paul D. Eve, Angela Hayes, et al.. (2010). The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106. Molecular Cancer Therapeutics. 9(1). 89–100. 63 indexed citations
4.
Matthews, Thomas P., Tatiana McHardy, Kathy Boxall, et al.. (2010). Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases. Bioorganic & Medicinal Chemistry Letters. 20(14). 4045–4049. 20 indexed citations
5.
Kristeleit, Rebecca, Peter C.C. Fong, G. Wynne Aherne, & Johann S. de Bono. (2005). Histone Deacetylase Inhibitors: Emerging Anticancer Therapeutic Agents?. Clinical Lung Cancer. 7. S19–S30. 20 indexed citations
6.
Jackman, Ann L., Rosemary Kimbell, Lisa Brunton, et al.. (2002). A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1587(2-3). 215–223. 9 indexed citations
7.
Farrugia, David, G. Wynne Aherne, Lisa Brunton, Stephen Clarke, & A.L. Jackman. (2000). Leucovorin rescue from raltitrexed (tomudex)-induced antiproliferative effects: in vitro cell line and in vivo mouse studies.. PubMed. 6(9). 3646–56. 18 indexed citations
8.
Aherne, G. Wynne, et al.. (1998). Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical models. British Journal of Cancer. 77(2). 221–226. 26 indexed citations
9.
Aherne, G. Wynne, et al.. (1998). Determination of morphine in urine by solid-phase immunoextraction and high-performance liquid chromatography with electrochemical detection. Journal of Chromatography A. 797(1-2). 245–250. 39 indexed citations
10.
Aherne, G. Wynne, Anthea Hardcastle, Florence I. Raynaud, & Ann L. Jackman. (1996). Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells. Biochemical Pharmacology. 51(10). 1293–1301. 48 indexed citations
11.
Aherne, G. Wynne, Anthea Hardcastle, Melanie Valenti, et al.. (1996). Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay. Cancer Chemotherapy and Pharmacology. 38(3). 225–232. 47 indexed citations
12.
Aherne, G. Wynne. (1992). The use of elisas for the detection and measurement of pollutants in water. Journal of Chemical Technology & Biotechnology. 54(2). 189–191.
13.
Aherne, G. Wynne, et al.. (1992). Visualisation of doxorubicin in human and animal tissues and in cell cultures by immunogold-silver staining. British Journal of Cancer. 65(1). 82–86. 7 indexed citations
14.
English, J., G. Wynne Aherne, & J Arendt. (1988). Modulation of the circadian rhythm in methotrexate toxicity in the rat by melatonin and photoperiod. 359–360. 1 indexed citations
15.
Poulain, P., Peter Hoskin, G.W. Hanks, et al.. (1988). RELATIVE BIOAVAILABILITY OF CONTROLLED RELEASE MORPHINE TABLETS (MST CONTINUS) IN CANCER PATIENTS. British Journal of Anaesthesia. 61(5). 569–574. 30 indexed citations
16.
Aherne, G. Wynne, et al.. (1984). A novel method for the quantitation of 6-mercaptopurine in human plasma using high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 309(2). 409–414. 22 indexed citations
17.
Hanks, G.W., et al.. (1981). CONTROLLED-RELEASE MORPHINE TABLETS. British Journal of Anaesthesia. 53(12). 1259–1264. 33 indexed citations
18.
Piall, E. M., G. Wynne Aherne, & V. Marks. (1979). A radioimmunoassay for cytosine arabinoside. British Journal of Cancer. 40(4). 548–556. 43 indexed citations
19.
Aherne, G. Wynne, V. Marks, G. P. Mould, E. M. Piall, & William F. White. (1978). The interaction between methotrexate and probenecid in man [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 369P–369P. 10 indexed citations
20.
Piall, E. M., et al.. (1975). Development of a radioimmunoassay for morphine having minimal cross- reactivity with codeine. Journal of Endocrinology. 64(1). 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy W. Synold Breakdown of academic impact, for papers by Dean J. Naisbitt Breakdown of academic impact, for papers by Hans Ehrsson Breakdown of academic impact, for papers by David C. Thompson Breakdown of academic impact, for papers by Hans Glaumann Breakdown of academic impact, for papers by Nicholas R. Bachur Breakdown of academic impact, for papers by Toshihisa Ishikawa Breakdown of academic impact, for papers by Michaël Thomas Breakdown of academic impact, for papers by E. A. de Bruijn Breakdown of academic impact, for papers by John L. Gollan
Rankless by CCL
2026